X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Butterfly Network, Inc.
BFLY
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
Last trade$5.85
Day change+$0.135 (+2.36%)
Day range$5.64 – $5.90
Volume2,970,677
Market cap$1.53B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$1.53B
Price / earnings
—
Price / book
8.28×
Price / sales
12.39×
EV / sales
11.4×
EV / EBITDA
-27.55×
Profitability
Earnings per share
-$0.20
Return on assets
-18.64%
Return on equity
-29.11%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
3.58×
Quick ratio
2.71×
Cash ratio
1.8×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$27.55M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for BFLY, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$32.6M
$32.61M
$26.53M
$31.51M
$21.49M
$23.38M
$21.23M
$22.35M
Cost of revenue
$8.8M
$9.32M
$8.25M
$10.29M
$25.25M
$8.49M
$7.85M
$8.62M
Gross profit
$23.8M
$23.29M
$18.29M
$21.22M
-$3.76M
$14.89M
$13.38M
$13.74M
Selling, general and administrative
$23.17M
$22.82M
$22.24M
$23.29M
$19.92M
$20.69M
$21.22M
$21.8M
Research and development
$10.17M
$10.54M
$9.54M
$9.32M
$8.7M
$8.32M
$9.92M
$8.83M
Total operating expenses
$37.38M
$36.95M
$32.16M
$37.93M
$31.38M
$30.99M
$31.85M
$31.05M
Operating income
-$13.58M
-$13.66M
-$13.87M
-$16.71M
-$35.13M
-$16.1M
-$18.47M
-$17.31M
Interest expense
-$284K
-$282K
-$279K
-$390K
-$385K
-$368K
-$347K
-$333K
Income before taxes
-$12.81M
-$12.91M
-$12.68M
-$15.23M
-$33.96M
-$13.81M
-$13.96M
-$18.21M
Income taxes
$0
$0
$0
$67K
$16K
$20K
$7K
-$110K
Net income
-$12.81M
-$12.91M
-$12.68M
-$15.29M
-$33.97M
-$13.83M
-$13.97M
-$18.1M
Net income attributable to common shareholders
-$12.81M
-$12.91M
-$12.68M
-$15.29M
-$33.97M
-$13.83M
-$13.97M
-$18.1M
EBITDA
-$11.96M
-$12M
-$12.06M
-$14.96M
-$33.25M
-$14.02M
-$16.11M
-$14.81M
Basic earnings per share
-$0.05
-$0.05
-$0.05
-$0.06
-$0.13
-$0.06
-$0.06
-$0.08
Diluted earnings per share
-$0.05
-$0.05
-$0.05
-$0.06
-$0.13
-$0.06
-$0.06
-$0.08
Recent news
Company coverage with links to the original publishers.
Butterfly Network reported a Q3 loss of $0.01 per share, beating consensus estimates of $0.03 loss, with a 66.67% earnings surprise. Revenue reached $32.6 million, surpassing estimates by 16.05% and up 51.7% year-over-year. The stock has gained 105.5% year-to-date but holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions.
The global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.
The Medical Information Systems industry is positioned for growth driven by AI integration in healthcare, with a projected 39.7% CAGR through 2031. However, rising cybersecurity threats pose significant risks. Three stocks—Inspire Medical Systems, American Well, and Butterfly Network—are well-positioned to benefit from demand for AI-powered solutions and digital health platforms, though the industry has underperformed the broader market over the past year.
Butterfly Network director Louise S. Phanstiel purchased 115,200 shares worth $1.0 million at $8.68 per share, increasing her total beneficial ownership to 691,413 shares (0.26% of the company). The insider purchase is viewed as a bullish signal, particularly given Phanstiel's healthcare expertise. Analysts project 19% revenue growth for the current fiscal year and expect the company to double its 2026 revenue by 2028 while narrowing net losses.
Butterfly Network founder Jonathan Rothberg sold approximately 660,000 shares (~$4.3 million) on July 22, 2026, under a pre-scheduled Rule 10b5-1 trading plan for estate planning purposes. While the sale was pre-planned, analysts note it's concerning timing given the stock's 250% surge over the past year and multiple recent insider sales. Despite positive analyst outlooks for 2026 revenue growth of 22%, investors are advised to reconsider their investment thesis given the founder's share liquidation near five-year highs.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.